S$0.15 Cordlife P8A.SI (SES) closes 04 Feb 2026: Oversold RSI hints bounce

Cordlife Group Limited (P8A.SI) on the Singapore Exchange closed at S$0.15 on 04 Feb 2026, leaving the name deeply oversold on technicals. The focus on P8A.SI stock is the near-term technical setup: RSI 26.88 and ADX 30.90 point to a strong trend with oversold momentum. Volume was muted versus the 50-day average, so any fresh buying could trigger a rapid short-term bounce. We examine technical triggers, valuation metrics, and model forecasts to frame a cautious oversold-bounce trade idea

P8A.SI stock: Technical setup for an oversold bounce

RSI is 26.88, in classic oversold territory. MACD sits at -0.01 with a flat signal line. ADX at 30.90 shows a strong trend is present. These indicators together favour a mean-reversion bounce rather than a structural reversal.

Bollinger Bands show a lower band at S$0.12 and an upper band at S$0.16, so a quick move toward S$0.16–S$0.18 is feasible if buying resumes. Average daily volume is 19,495.00 shares, so liquidity will influence how fast prices move.

P8A.SI stock: Fundamentals and valuation

Cordlife reported trailing EPS of -0.05 and a negative P/E of -3.00, reflecting recent losses. Price-to-book is 0.34, below parity, which signals low market valuation relative to book value.

Market capitalisation stands at SGD 38,446,162.00 with 256,307,744.00 shares outstanding. The firm trades below its 200-day average of S$0.20 and slightly above its 50-day average of S$0.14, which supports an argument for tactical recovery if sentiment improves.

P8A.SI stock: Cash flow, balance sheet and operational metrics

Cordlife has cash per share S$0.20 and a current ratio of 3.13, indicating short-term liquidity cover. Free cash flow per share is negative at -0.03, showing operating cash strain despite cash reserves.

Receivables turnover is low and days sales outstanding is 255.59 days, which increases working capital risk. Debt is minimal with debt-to-equity around 0.01, keeping leverage low relative to peers in Healthcare.

P8A.SI stock: Catalysts, sector context and risks

Sector momentum in Singapore Healthcare has been mixed, with year-to-date performance near -0.27% for the sector. Cordlife’s Diagnostics and Banking segments provide diversified revenue streams but growth is uneven.

Key risks: low liquidity (volume 0.00 on the last close), extended receivables, and continued negative EPS. No imminent earnings date is listed, so catalysts likely come from operational updates or renewed investor interest. Watch regulatory or partnership news for material moves

P8A.SI stock: Trading plan for an oversold bounce

For traders seeking an oversold-bounce setup, a short-term target of S$0.18 is reasonable, with a stretch target at S$0.25 if momentum improves. Place disciplined risk limits: a stop-loss near S$0.13 limits downside on failed bounces.

Given low average volume, size positions conservatively and confirm with increased volume above 19,495.00 shares or a break above the Bollinger middle at S$0.14 before adding exposure.

Meyka AI grade and forecast for P8A.SI stock

Meyka AI rates P8A.SI with a score of 58 out of 100 — Grade C+ (HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects monthly S$0.03 and quarterly S$0.10. Against the current price of S$0.15, the quarterly model implies -33.33% downside and the monthly model implies -80.00% downside. Forecasts are model-based projections and not guarantees. Use them together with technical signals for trade timing.

See the stock page for live updates: Cordlife P8A.SI on Meyka

Final Thoughts

P8A.SI stock closed at S$0.15 on 04 Feb 2026 with clear technical signs of being oversold. The combination of RSI 26.88 and ADX 30.90 supports a tactical oversold-bounce play, but the company’s negative EPS (-0.05) and weak cash flow require caution. Short-term traders can target S$0.18 with a tight stop at S$0.13 and scale out into strength. Longer-term investors should weigh a low price-to-book of 0.34 and cash per share S$0.20 against persistent receivable days and negative profitability. Meyka AI’s model projects quarterly S$0.10 versus the current S$0.15, signalling model-driven downside; yet technical bounce scenarios remain plausible if volume returns. These views are market analysis, not personal advice. Monitor liquidity, any operational updates, and sector moves before increasing exposure

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.